mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.08 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.09 |
0.08 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.055 |
0.09 |
mRNA |
fluvastatin |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |